<?xml version="1.0" encoding="UTF-8"?>
<ref id="hep41480-bib-0056">
 <label>56</label>
 <mixed-citation publication-type="journal" id="hep41480-cit-0056">
  <string-name>
   <surname>Cornberg</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Lok</surname>
   <given-names>AS‐F</given-names>
  </string-name>, 
  <string-name>
   <surname>Terrault</surname>
   <given-names>NA</given-names>
  </string-name>, 
  <string-name>
   <surname>Zoulim</surname>
   <given-names>F</given-names>
  </string-name>, 
  <string-name>
   <surname>Berg</surname>
   <given-names>T</given-names>
  </string-name>, 
  <string-name>
   <surname>Brunetto</surname>
   <given-names>MR</given-names>
  </string-name>, et al. 
  <article-title>Guidance for design and endpoints of clinical trials in chronic hepatitis B‐report from the 2019 EASL‐AASLD HBV Treatment Endpoints Conference</article-title>. 
  <source xml:lang="en">Hepatology</source>
  <year>2019</year> Nov 12. 
  <pub-id pub-id-type="doi">10.1002/hep.31030</pub-id>. [Epub ahead of print]
 </mixed-citation>
</ref>
